Results 21 to 30 of about 210,954 (254)

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies

open access: yesFrontiers in Pharmacology, 2023
Cholestasis is a common clinical disease caused by a disorder in bile acids (BAs) homeostasis, which promotes its development. The Farnesoid X receptor (FXR) plays a critical role in regulating BAs homeostasis, making it an essential target for ...
Lili Xi   +5 more
doaj   +1 more source

Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma [PDF]

open access: yes, 2006
In acute asthma inhaled beta 2-agonists are often administered to relieve bronchospasm by wet nebulisation, but some have argued that metered-dose inhalers with a holding chamber (spacer) can be equally effective.
Christopher J Cates   +5 more
core   +1 more source

Immune Checkpoints as Therapeutic Targets in Autoimmunity

open access: yesFrontiers in Immunology, 2018
Antibodies that block the immune checkpoint receptors PD1 and CTLA4 have revolutionized the treatment of melanoma and several other cancers, but in the process, a new class of drug side effect has emerged—immune related adverse events.
Christopher Paluch   +9 more
doaj   +1 more source

Transcriptome analysis of endometrial tissues following GnRH agonist treatment in a mouse adenomyosis model [PDF]

open access: yes, 2017
Song Guo,1,* Xiaowei Lu,1,* Ruihuan Gu,2 Di Zhang,3 Yijuan Sun,2 Yun Feng1 1Department of Obstetrics and Gynecology, Reproductive Medicine Center, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, People’s ...
Gu R   +11 more
core   +1 more source

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity

open access: yesFrontiers in Immunology, 2022
Tumor necrosis factor (TNF) receptor-2 (TNFR2) has attracted considerable interest as a target for immunotherapy. Indeed, using oligomeric fusion proteins of single chain-encoded TNFR2-specific TNF mutants (scTNF80), expansion of regulatory T cells and ...
Juan Gamboa Vargas   +20 more
doaj   +1 more source

Effective Improvement of Symptoms in Patients with Acute Migraine by GR43175 Administered in Dispersible Tablets [PDF]

open access: yes, 1989
GR43175, a selective 5-HT1-like agonist, was administered as oral dispersible tablets in an open, uncontrolled dose-ranging study to assess its efficacy as an agent for acute migraine.
Dönicke, A.   +2 more
core   +1 more source

Agonist and inverse agonist pharmacology revealed by quantitative assessment of ghrelin receptor internalisation [Abstract]

open access: yes, 2011
Agonist and inverse agonist pharmacology revealed by quantitative assessment of ghrelin receptor internalisation [Abstract]
Tim Self (14857156)   +2 more
core   +5 more sources

Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists

open access: yesFrontiers in Immunology, 2023
The extracellular domain of tumor necrosis factor receptors (TNFR) generally require assembly into a homotrimeric quaternary structure as a prerequisite for initiation of signaling via the cytoplasmic domains.
George Fromm   +2 more
doaj   +1 more source

TLR9/NF-kB Pathway Regulates Brucella CpG DNA-mediated Cytokine Response in Human Peripheral Blood Mononuclear Cells [PDF]

open access: yesIranian Journal of Immunology, 2021
Background: It was reported that targeting the Toll-like receptor9(TLR9) signaling pathway can be a promising therapeuticstrategy forinterventions in various inflammatory and infectiousdiseases.
Yunzhi Peng   +3 more
doaj   +1 more source

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke [PDF]

open access: yes, 2012
Hemispatial neglect following right-hemisphere stroke is a common and disabling disorder, for which there is currently no effective pharmacological treatment. Dopamine agonists have been shown to play a role in selective attention and working memory, two
Kulinskaya, Elena   +26 more
core   +1 more source

Home - About - Disclaimer - Privacy